Skip to content

Multiple Sclerosis Rehabilitation Study

'Functioning and Disability' and 'Quality of Life' in an Australian Community Cohort With Multiple Sclerosis.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00202254
Enrollment
100
Registered
2005-09-20
Start date
2004-12-31
Completion date
2005-12-31
Last updated
2015-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Mulitple Sclerosis, MS

Brief summary

The effects of routine rehabilitation in MS patients versus no rehabilitation.

Detailed description

Routine rehabilitation inervention in patients with MS. This comprises of medical and nursing input, physiotherapy, occupational therapy, speech pathology, neuropsychology, compared with a control group on the waiting list for rehabilitation intervention. Duration of intervention is 6 weeks.

Interventions

BEHAVIORALPhysiotherapy
BEHAVIORALOccupational therapy
BEHAVIORALSpeech pathology

Sponsors

Melbourne Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of MS (Paty)- Community dwelling participants with known neurological and psychological deficits per EDSS groups.- Age 19-64 years.- Male and female participants.- Residing within 60kms of metropolitan Melbourne.- Have mobility problem.- Adequate cognition (KFS=2).

Exclusion criteria

* Patients residing in nursing home and other residential care.- Those with severe cognitive problems KFS\>2.-

Design outcomes

Primary

MeasureTime frame
Improvement in fatigue levels and psychological well being (depression, stress and anxiety) in MS patients. Outcome will be measured at 13 months since recruitment.

Secondary

MeasureTime frame
- Improvement in function and activities of daily living ie. disability- Quality of life.- Carer Burder in multiple sclerosis.- Utilisation of health services.- 13 months follow up.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026